Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol
2. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-r)-
3. Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine Methanol
4. M100907
5. Mdl 100,907
6. Mdl 100105
7. Mdl 100907
8. Mdl-100,907
9. Mdl-100907
10. Mdl100105
1. 139290-65-6
2. Mdl 100907
3. Mdl-100907
4. M100907
5. (r)-(2,3-dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol
6. Volinanserin [inn]
7. Mdl100907
8. Mdl-100,907
9. Mdl100.907
10. (r)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol
11. Chembl74355
12. C22h28fno3
13. Ew71ee171j
14. M-100907
15. Mdl-100.907
16. (r)-(2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol
17. (r)-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluoro-phenyl)ethyl]-4-piperidine Methanol
18. Mdl 100,907
19. Unii-ew71ee171j
20. Mdl 100009
21. Serotonin 5-ht2 Receptor Antagonists
22. Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine Methanol
23. Dsstox_cid_27363
24. Dsstox_rid_82298
25. Dsstox_gsid_47363
26. Gtpl185
27. Schembl675164
28. Dtxsid6047363
29. (2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol
30. Zinc598040
31. Ex-a3509
32. Tox21_300244
33. Bdbm50095027
34. Mfcd00909060
35. Akos022180892
36. (r)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol
37. Ncgc00247964-01
38. Ncgc00254173-01
39. Ac-36402
40. As-35103
41. Hy-14940
42. Cas-139290-65-6
43. Cs-0003646
44. S0313
45. M100907, >=98% (hplc)
46. A886060
47. Mdl 100907, (r)-(+)-
48. M 100907
49. Q7940202
50. (r)-(1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethoxyphenyl)methanol
51. (r)-(+)-?-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperinemethanol
52. (r)-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2 -(4-fluorophenyl)ethyl]-4-piperinemethanol
53. (r)-(2,3-dimethoxyphenyl)-(1-(2-p-fluorophenylethyl)-piperidine-4-yl)-methanol
54. (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
55. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (+)-
56. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-, (alphar)-
57. (2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol (m 100907)
58. (2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol(mdl 100907)
59. 4-piperidinemethanol, .alpha.-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (.alpha.r)-
60. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (r)-
| Molecular Weight | 373.5 g/mol |
|---|---|
| Molecular Formula | C22H28FNO3 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 373.20532192 g/mol |
| Monoisotopic Mass | 373.20532192 g/mol |
| Topological Polar Surface Area | 41.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 422 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
ABOUT THIS PAGE
A Volinanserin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Volinanserin, including repackagers and relabelers. The FDA regulates Volinanserin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Volinanserin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Volinanserin supplier is an individual or a company that provides Volinanserin active pharmaceutical ingredient (API) or Volinanserin finished formulations upon request. The Volinanserin suppliers may include Volinanserin API manufacturers, exporters, distributors and traders.
click here to find a list of Volinanserin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Volinanserin DMF (Drug Master File) is a document detailing the whole manufacturing process of Volinanserin active pharmaceutical ingredient (API) in detail. Different forms of Volinanserin DMFs exist exist since differing nations have different regulations, such as Volinanserin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Volinanserin DMF submitted to regulatory agencies in the US is known as a USDMF. Volinanserin USDMF includes data on Volinanserin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Volinanserin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Volinanserin suppliers with USDMF on PharmaCompass.
Volinanserin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Volinanserin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Volinanserin GMP manufacturer or Volinanserin GMP API supplier for your needs.
A Volinanserin CoA (Certificate of Analysis) is a formal document that attests to Volinanserin's compliance with Volinanserin specifications and serves as a tool for batch-level quality control.
Volinanserin CoA mostly includes findings from lab analyses of a specific batch. For each Volinanserin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Volinanserin may be tested according to a variety of international standards, such as European Pharmacopoeia (Volinanserin EP), Volinanserin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Volinanserin USP).
LOOKING FOR A SUPPLIER?
